Publications by authors named "Alain Castaigne"

Claim this Profile
[
[State of unmet medical needs in France in 2006: necessity of reinforcing research effort].
Chrystel Jouan-Flahault, Nathalie Billon, Alain Castaigne, Yves-Dominique Henry, Carole Omnes

Therapie· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lifestyle and cardiovascular risk].
Alain Castaigne, Denis Pouchain

Rev Prat· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study.
Guiseppe Mancia, Luis Ruilope, Christopher Palmer, Morris Brown, Alain Castaigne

Blood Press· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
Peter W de Leeuw, Luis M Ruilope, Christopher R Palmer, Morris J Brown, Alain Castaigne

Arch Intern Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Franz Hartmann, Milton Packer, Andrew J S Coats, Michael B Fowler, Henry Krum, Alain Castaigne

Circulation· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
Jean L Rouleau, Ellen B Roecker, Michal Tendera, Paul Mohacsi, Henry Krum, Alain Castaigne

J Am Coll Cardiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
Franz Hartmann, Milton Packer, Andrew J S Coats, Michael B Fowler, Henry Krum, Alain Castaigne

Eur J Heart Fail· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
Giuseppe Mancia, Morris Brown, Alain Castaigne, Peter de Leeuw, Christopher R Palmer

Hypertension· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Framingham prediction rule is not valid in a European population of treated hypertensive patients.
Sylvie Bastuji-Garin, Anne Deverly, Dominique Moyse, Alain Castaigne, Giuseppe Mancia

J Hypertens· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?
Pascal Merlet, Luc Hittinger, Jean Luc Dubois-Randé, Alain Castaigne

J Nucl Med· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Role of drugs in therapeutic strategies].
Alain Castaigne

Rev Prat· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reassessment of drugs].
Alain Castaigne

Rev Prat· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis